The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Renschler Markus Md since 2022.
This trader's CIK number is 1217598.
At the time of last reporting, Renschler Markus Md was the President and CEO of Cyteir Therapeutics, Inc.. (stock ticker symbol CYT).
Also see all insider trading activities at Cyteir Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | CYT | 0 | $0 | 0 | $0 | 21,448 | $32,536 |
2023 | CYT | 0 | $0 | 0 | $0 | 93,477 | $135,073 |
2022 | CYT | 0 | $0 | 0 | $0 | 136,782 | $152,511 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-03-04 | CYT | Option Ex | 6,304 | 1.69 | 10,653 |
2024-02-29 | CYT | Option Ex | 15,144 | 1.45 | 21,883 |
2023-11-20 | CYT | Option Ex | 8,840 | 1.45 | 12,773 |
2023-11-20 | CYT | Option Ex | 84,637 | 1.45 | 122,300 |
2022-12-21 | CYT | Option Ex | 136,782 | 1.11 | 152,511 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Renschler Markus Md (President and CEO of Cyteir Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.